HNRNPAB and cancer: The GSCA database was used to examine the role of EME1/HNRNPAB/PLAUR/SEMA3A in 10 cancer pathways and found that EME1 was mainly involved in the activation of apoptosis, cell cycle and DNA damage response and inhibition of RAS/MAPK pathways.